{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:49:27Z","timestamp":1774565367464,"version":"3.50.1"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,7,1]]},"abstract":"<jats:p>Objectives.\u2003To examine the safety and pharmacokinetics of multiple intratracheal (IT) doses of recombinant human CuZn superoxide dismutase (rhSOD) in premature infants with respiratory distress syndrome who are at risk for developing bronchopulmonary dysplasia (BPD).<\/jats:p><jats:p>Methods.\u2003Thirty-three infants (700 to 1300 g) were randomized and blindly received saline, 2.5 mg\/kg or 5 mg\/kg rhSOD IT within 2 hours of surfactant administration. Infants were treated every 48 hours (as long as endotracheal intubation was required) up to 7 doses. Serial blood and urine studies, chest radiographs, neurosonograms, SOD concentration and activity measurements, and tracheal aspirate (TA) inflammatory markers were assessed throughout the 28-day study.<\/jats:p><jats:p>Results.\u2003SOD concentrations in serum (0.1 [0.05\/0.15] \u03bcg\/mL\u2013geometric mean with lower\/upper confidence intervals), tracheal aspirates (TA) (0.2 [0.1\/0.3] \u03bcg\/mL) and urine (0.3 [0.2\/0.4] \u03bcg\/mL) were similar at baseline in all 3 groups and did not change significantly in the placebo group. In the rhSOD treatment groups, SOD concentrations were increased on day 3 and did not change significantly thereafter over the 14-day dosing period (also measured on days 5, 7, and 13). SOD concentrations averaged 0.4 [0.3\/0.5] \u03bcg\/mL in serum, 0.8 [0.6\/1.2] \u03bcg\/mL in TA and 1.1 [1.0\/1.3] \u03bcg\/mL in urine for the low-dose group and 0.6 [0.5\/0.7] \u03bcg\/mL in serum, 1.1 [0.9\/1.5] \u03bcg\/mL in TA, and 2.2 [1.6\/2.9] \u03bcg\/mL in urine for the high-dose group over the 14-day dosing period. Enzyme activity directly correlated with SOD concentration and rhSOD was active even when excreted in urine. TA markers of acute lung injury (neutrophil chemotactic activity, albumin concentration) were lower in the rhSOD agroups compared with placebo. No significant differences in any clinical outcome variable were noted between groups.<\/jats:p><jats:p>Conclusions.\u2003These data indicate that multiple IT doses of rhSOD increase the concentration and activity of the enzyme in serum, TA and urine, reduce TA lung injury markers and are well-tolerated. Further clinical trials examining the efficacy of rhSOD in the prevention of BPD are warranted.<\/jats:p>","DOI":"10.1542\/peds.100.1.24","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:40:17Z","timestamp":1092440417000},"page":"24-30","source":"Crossref","is-referenced-by-count":91,"title":["Safety and Pharmacokinetics of Multiple Doses of Recombinant Human CuZn Superoxide Dismutase Administered Intratracheally to Premature Neonates With Respiratory Distress Syndrome"],"prefix":"10.1542","volume":"100","author":[{"given":"Jonathan M.","family":"Davis","sequence":"first","affiliation":[{"name":"From the Departments of Pediatrics (Neonatology),"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren N.","family":"Rosenfeld","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics (Neonatology),"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Richter","sequence":"additional","affiliation":[{"name":"From the Departments of Pediatrics (Neonatology),"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Parad","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira H.","family":"Gewolb","sequence":"additional","affiliation":[{"name":"University of Maryland Medical Center, Baltimore MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Spitzer","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University Medical Center, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Couser","sequence":"additional","affiliation":[{"name":"Children's Healthcare-Minneapolis, Minneapolis, MN; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Price","sequence":"additional","affiliation":[{"name":"Radiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Flaster","sequence":"additional","affiliation":[{"name":"Biostatistics, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim","family":"Kassem","sequence":"additional","affiliation":[{"name":"Bio-Technology General Corp, Iselin, NJ; for the North American rhSOD Study Group."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Edwards","sequence":"additional","affiliation":[{"name":"Bio-Technology General Corp, Iselin, NJ; for the North American rhSOD Study Group."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Tierney","sequence":"additional","affiliation":[{"name":"CardioPulmonary Research Institute, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Horowitz","sequence":"additional","affiliation":[{"name":"CardioPulmonary Research Institute, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1997,7,1]]},"reference":[{"key":"2021120916534024900_B1"},{"key":"2021120916534024900_B2"},{"key":"2021120916534024900_B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ppul.1950110111","article-title":"Surfactant replacement therapy: state of the art.","volume":"11","author":"Yee","year":"1991","journal-title":"Pediatr Pulmonol"},{"key":"2021120916534024900_B4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM198808253190804","article-title":"Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.","volume":"319","author":"Davis","year":"1988","journal-title":"N Engl J Med"},{"key":"2021120916534024900_B5"},{"key":"2021120916534024900_B6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1203\/00006450-198403000-00004","article-title":"Preparation for birth into an O2 rich environment: the antioxidant enzymes in the developing rabbit lung.","volume":"18","author":"Frank","year":"1984","journal-title":"Pediatr Res"},{"key":"2021120916534024900_B7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0891-5849(91)90062-8","article-title":"Developmental aspects of experimental pulmonary oxygen toxicity.","volume":"11","author":"Frank","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"2021120916534024900_B8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1152\/jappl.1993.74.5.2234","article-title":"Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury.","volume":"74","author":"Davis","year":"1993","journal-title":"J Appl Physiol"},{"key":"2021120916534024900_B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1172\/JCI111210","article-title":"Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.","volume":"73","author":"Turrens","year":"1984","journal-title":"J Clin Invest"},{"key":"2021120916534024900_B10","first-page":"164","article-title":"Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase.","volume":"132","author":"Padmanabhan","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2021120916534024900_B11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.97.6.811","article-title":"Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.","volume":"97","author":"Rosenfeld","year":"1996","journal-title":"Pediatr"},{"key":"2021120916534024900_B12","first-page":"330A","article-title":"Improved pulmonary distribution of recombinant human superoxide dismutase using a modified ultrasonic nebulizer.","volume":"35","author":"Davis","year":"1994","journal-title":"Pediatr Res."},{"key":"2021120916534024900_B13","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase: an enzymatic function for erythrocuprein.","volume":"244","author":"McCord","year":"1969","journal-title":"J Biol Chem"},{"key":"2021120916534024900_B14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","article-title":"Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.","volume":"44","author":"Beauchamp","year":"1971","journal-title":"Anal Biochem"},{"key":"2021120916534024900_B15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1172\/JCI111015","article-title":"Elastase and \u03b1-1 proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.","volume":"72","author":"Merritt","year":"1983","journal-title":"J Clin Invest"},{"key":"2021120916534024900_B16","first-page":"581","article-title":"Clinical and radiographic scoring systems for assessing bronchopulmonary dysplasia.","volume":"138","author":"Toce","year":"1984","journal-title":"Am J Dis Child"},{"key":"2021120916534024900_B17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.82.4.527","article-title":"Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period.","volume":"82","author":"Shennan","year":"1988","journal-title":"Pediatrics"},{"key":"2021120916534024900_B18"},{"key":"2021120916534024900_B19","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.1074\/jbc.271.25.15182","article-title":"Cellular oxygen toxicity.","volume":"271","author":"Kazzaz","year":"1996","journal-title":"J Biol Chem"},{"key":"2021120916534024900_B20","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1073\/pnas.92.14.6264","article-title":"Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia.","volume":"92","author":"Carlsson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021120916534024900_B21","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.1016\/S0021-9258(18)35927-1","article-title":"Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury.","volume":"267","author":"Wispe","year":"1992","journal-title":"J Biol Chem"},{"key":"2021120916534024900_B22"},{"key":"2021120916534024900_B23","first-page":"393A","article-title":"Superoxide generation and killing of three important bacterial pathogens by neonatal neutrophils: effects of exogenous superoxide dismutase.","volume":"20","author":"Tosi","year":"1986","journal-title":"Pediatr Res"},{"key":"2021120916534024900_B24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(96)70191-9","article-title":"Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Health and Human Development Neonatal Research Network.","volume":"129","author":"Stoll","year":"1996","journal-title":"J Pediatr"},{"key":"2021120916534024900_B25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1203\/00006450-199408000-00017","article-title":"Increased activity of interleukin-6 but not tumor necrosis factor \u03b1 in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia.","volume":"36","author":"Bagchi","year":"1994","journal-title":"Pediatr Res"},{"key":"2021120916534024900_B26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3171\/jns.1985.62.4.0563","article-title":"Beagle puppy model of intraventricular hemorrhage: effect of superoxide dismutase on cerebral blood flow and prostaglandins.","volume":"62","author":"Ment","year":"1985","journal-title":"J Neurosurg"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/100\/1\/24\/889420\/pe079700024o.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/100\/1\/24\/889420\/pe079700024o.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:32:59Z","timestamp":1734507179000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/100\/1\/24\/38877\/Safety-and-Pharmacokinetics-of-Multiple-Doses-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7,1]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1997,7,1]]},"published-print":{"date-parts":[[1997,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.100.1.24","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1997,7,1]]}}}